Members |
targetComponentId |
Occupation of spouse |
Occupation of husband (observable entity) |
Occupation of spouse |
Occupation of wife (observable entity) |
Occupation of spouse |
Occupation of spouse (observable entity) |
Occupation of wife |
Occupation of wife (observable entity) |
Occupational allergen |
Substance |
Occupational allergen specific diagnostic allergen extract |
Diagnostic allergen extract (product) |
Occupational allergic contact dermatitis caused by agrochemical biocide |
Occupational allergic contact dermatitis caused by biocide |
Occupational allergic contact dermatitis caused by food additive |
Occupational allergic contact dermatitis |
Occupational allergic contact dermatitis caused by food additive |
Allergic contact dermatitis caused by food in contact with skin (disorder) |
Occupational allergic contact dermatitis caused by food flavor |
Allergic contact dermatitis caused by food in contact with skin (disorder) |
Occupational allergic contact dermatitis caused by food flavor |
Occupational allergic contact dermatitis |
Occupational allergic contact dermatitis caused by industrial preservative |
Contact dermatitis caused by preservatives (disorder) |
Occupational allergic contact dermatitis caused by industrial preservative |
Occupational contact dermatitis (disorder) |
Occupational allergic contact dermatitis caused by systemic drug or medicament |
Occupational allergic contact dermatitis |
Occupational allergic contact dermatitis caused by topical medicament |
Occupational allergic contact dermatitis |
Occupational eczema |
Occupational contact dermatitis (disorder) |
Occupational eczema |
Occupational contact dermatitis (disorder) |
Occupational eczema |
Occupational allergic contact dermatitis |
Ochrobactrum species |
Ochrobactrum |
Ochroconis species |
Ochroconis |
Ochronosis |
Exogenous ochronosis (disorder) |
Ochronosis |
Ochronosis due to homogentisate 1,2-dioxygenase deficiency (disorder) |
Octatropine methylbromide |
Product containing anisotropine (medicinal product) |
Octenedate measurement |
Measurement of substance (procedure) |
Octreotide 100micrograms/mL injection solution 1mL ampule |
Product containing precisely octreotide (as octreotide acetate) 100 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Octreotide 10mg powder and solvent for injection suspension vial |
Product containing precisely octreotide (as octreotide acetate) 10 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Octreotide 200micrograms/mL injection solution 5mL vial |
Product containing precisely octreotide (as octreotide acetate) 200 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Octreotide 20mg powder and solvent for injection suspension vial |
Product containing precisely octreotide (as octreotide acetate) 20 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Octreotide 30mg powder and solvent for injection suspension vial |
Octreotide (as octreotide acetate) 30 mg powder for suspension for injection vial |
Octreotide 500micrograms/mL injection solution 1mL ampule |
Product containing precisely octreotide (as octreotide acetate) 500 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Octreotide 50micrograms/mL injection solution 1mL ampule |
Octreotide (as octreotide acetate) 50 microgram/mL solution for injection |
Octreotide acetate 0.1mg/mL injection |
Product containing precisely octreotide (as octreotide acetate) 100 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Octreotide acetate 0.2mg/mL injection |
Product containing precisely octreotide (as octreotide acetate) 200 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Octreotide acetate 0.5mg/mL injection |
Product containing precisely octreotide (as octreotide acetate) 500 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Octreotide acetate 100mcg/mL injection solution ampule |
Product containing precisely octreotide (as octreotide acetate) 100 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Octreotide acetate 10mg depot injection |
Product containing precisely octreotide (as octreotide acetate) 10 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Octreotide acetate 200mcg/mL injection solution ampule |
Product containing precisely octreotide (as octreotide acetate) 200 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Octreotide acetate 20mg depot injection |
Product containing precisely octreotide (as octreotide acetate) 20 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Octreotide acetate 30mg depot injection |
Octreotide (as octreotide acetate) 30 mg powder for suspension for injection vial |
Octreotide acetate 500mcg/mL injection solution ampule |
Product containing precisely octreotide (as octreotide acetate) 500 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Octreotide acetate 50mcg/mL injection |
Octreotide (as octreotide acetate) 50 microgram/mL solution for injection |
Octreotide acetate 50mcg/mL injection solution ampule |
Octreotide (as octreotide acetate) 50 microgram/mL solution for injection |
Ocular albinism, type II |
Aland Islands eye disease (disorder) |
Ocular albinism, type II |
Aland Islands eye disease (disorder) |
Ocular dissociation |
Strabismus |
Ocular lymphoma |
Malignant lymphoma of the eye region (disorder) |
Ocular lymphoma |
Intraocular non-Hodgkin malignant lymphoma (disorder) |
Ocular monitoring/recording system ambulatory antenna, single-use |
Patient worn ocular monitoring and recording antenna |
Ocular monitoring/recording system patient-worn antenna, reusable |
Patient worn ocular monitoring and recording antenna |
Ocular muscular dystrophy |
Oculopharyngeal muscular dystrophy |
Ocular muscular dystrophy |
Oculopharyngeal muscular dystrophy |
Ocular-mucous membrane syndrome |
Benign mucous membrane pemphigoid |
Ocular-mucous membrane syndrome |
Stevens-Johnson syndrome |
Oculocerebral dysplasia syndrome |
Hypoplasia of the optic nerve |
Oculocerebral dysplasia syndrome |
Aplasia of optic nerve (disorder) |
Oculomotor nerve and its branches |
Entire oculomotor nerve |
Oculomotor nerve and its branches |
Oculomotor nerve structure |
Odontogenic ghost cell tumor |
Odontogenic ghost cell neoplasm (morphologic abnormality) |
Odontogenic ghost cell tumor |
Benign odontogenic ghost cell neoplasm (morphologic abnormality) |
Odor detection sense, function (observable entity) |
Odor detection sense, function (observable entity) |
Odor detection sense, function (observable entity) |
Ability to detect odor (observable entity) |
Odor identification sense, function (observable entity) |
Ability to identify odor (observable entity) |
Odor identification sense, function (observable entity) |
Odor identification sense, function (observable entity) |
Odoribacter species |
Odoribacter |
Oedema (& [symptom] or [swelling symptom]) |
Swelling |
Oedema (& [symptom] or [swelling symptom]) |
Swelling |
Oedema (& [symptom] or [swelling symptom]) |
Oedema |
Oedema (& [symptom] or [swelling symptom]) |
Oedema |
Oenococcus species |
Oenococcus |
Oerskovia species |
Oerskovia |
Oesophageal &/or stomach &/or duodenal diseases |
Disorder of duodenum |
Oesophageal &/or stomach &/or duodenal diseases |
Disorder of esophagus |
Oesophageal &/or stomach &/or duodenal diseases |
Disorder of stomach |
Oesophageal intubation: [NEC] or [Sengstaken-Blakemore] |
Balloon tamponade of oesophagus using Sengstaken-Blakemore tube |
Oesophageal reflux (& [without mention of oesophagitis]) |
Gastro-oesophageal reflux disease without oesophagitis |
Oesophageal reflux (& [without mention of oesophagitis]) |
Gastroesophageal reflux disease |
Oesophageal stricture &/or stenosis |
Stricture of esophagus |
Oesophageal stricture &/or stenosis |
Stricture of esophagus |
Oesophageal varices in alcoholic cirrhosis of the liver |
Esophageal varices due to alcoholic cirrhosis of liver |
Oesophageal varices in cirrhosis of the liver |
Esophageal varices due to cirrhosis of liver (disorder) |
Oesophageal varices operation: [OS open] or [Tanner] |
Open operations on oesophageal varices |
Oesophageal, stomach and duodenal diseases |
Disorder of esophagus |
Oesophageal, stomach and duodenal diseases |
Disorder of stomach |
Oesophageal, stomach and duodenal diseases |
Disorder of duodenum |
Oesophageal, stomach or duodenal disorder NOS |
Disorder of duodenum |
Oesophageal, stomach or duodenal disorder NOS |
Disorder of esophagus |
Oesophageal, stomach or duodenal disorder NOS |
Disorder of stomach |
Oesophagectomy: [partial NOS] or [NEC] |
Esophagectomy |
Oesophagitis (& [reflux]) or oesophageal reflux |
Gastro-esophageal reflux disease with esophagitis |
Oesophagitis (& [reflux]) or oesophageal reflux |
Esophagitis |
Oesophagitis (& [reflux]) or oesophageal reflux |
Gastroesophageal reflux disease |
Oesophagitis (& [reflux]) or oesophageal reflux |
Esophagitis |
Oesophagitis (& [reflux]) or oesophageal reflux |
Esophageal reflux finding |
Oesophagitis (& [reflux]) or oesophageal reflux |
Gastroesophageal reflux disease |
Oesophagitis (& [reflux]) or oesophageal reflux |
Gastro-esophageal reflux disease with esophagitis |
Oesophagogastrectomy (& [anastomosis oesophagus to stomach] or [Bancroft] or [Ivor Lewis]) |
Partial oesophagectomy and proximal gastrectomy |
Oesophagogastrectomy (& [anastomosis oesophagus to stomach] or [Bancroft] or [Ivor Lewis]) |
Ivor Lewis partial oesophagogastrectomy |
Oesophagogastrectomy (& [anastomosis oesophagus to stomach] or [Bancroft] or [Ivor Lewis]) |
Esophagogastrectomy |
Oesophagogastrectomy (& [anastomosis oesophagus to stomach] or [Bancroft] or [Ivor Lewis]) |
Bancroft partial gastrectomy and oesophagogastrostomy |
Oesophagogastric fundoplasty (& [Thal] or [Nissen]) |
Esophagogastric fundoplasty |
Oesophagogastric fundoplasty (& [Thal] or [Nissen]) |
Total fundoplication |